ConvaTec Group (LON:CTEC) Given “Buy” Rating at Jefferies Financial Group

ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reissued by equities research analysts at Jefferies Financial Group in a note issued to investors on Wednesday,London Stock Exchange reports. They currently have a GBX 300 price objective on the stock. Jefferies Financial Group’s target price points to a potential upside of 32.98% from the stock’s previous close.

Several other research analysts have also issued reports on CTEC. JPMorgan Chase & Co. lowered their target price on ConvaTec Group from GBX 307 to GBX 294 and set an “overweight” rating for the company in a research report on Friday, May 22nd. Royal Bank Of Canada reiterated an “outperform” rating and issued a GBX 315 price target on shares of ConvaTec Group in a research report on Monday. Berenberg Bank reissued a “buy” rating and issued a GBX 340 price target on shares of ConvaTec Group in a research note on Tuesday, April 21st. Citigroup decreased their price target on ConvaTec Group from GBX 250 to GBX 230 and set a “neutral” rating for the company in a research note on Monday, May 18th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 315 price objective on shares of ConvaTec Group in a research report on Wednesday, April 8th. Eight investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 306.

ConvaTec Group Trading Down 1.7%

Shares of ConvaTec Group stock traded down GBX 3.80 during trading on Wednesday, hitting GBX 225.60. The company’s stock had a trading volume of 16,583,473 shares, compared to its average volume of 41,480,781. The company has a debt-to-equity ratio of 99.96, a current ratio of 1.53 and a quick ratio of 0.96. ConvaTec Group has a 52 week low of GBX 193 and a 52 week high of GBX 259.30. The stock has a market cap of £4.41 billion, a price-to-earnings ratio of 26.23, a price-to-earnings-growth ratio of 0.93 and a beta of 0.77. The stock has a 50-day moving average price of GBX 211.76 and a two-hundred day moving average price of GBX 221.09.

Insider Buying and Selling at ConvaTec Group

In other news, insider Jonny Mason acquired 50,000 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The stock was bought at an average cost of GBX 201 per share, for a total transaction of £100,500. 0.98% of the stock is currently owned by company insiders.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.